109 related articles for article (PubMed ID: 10102466)
1. Antibodies to factor XII associated with lupus anticoagulant.
Jones DW; Gallimore MJ; Harris SL; Winter M
Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
[TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
3. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
[TBL] [Abstract][Full Text] [Related]
4. Factor XII determinations in the presence and absence of phospholipid antibodies.
Gallimore MJ; Jones DW; Winter M
Thromb Haemost; 1998 Jan; 79(1):87-90. PubMed ID: 9459329
[TBL] [Abstract][Full Text] [Related]
5. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
8. The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses.
Inomo A; Sugi T; Fujita Y; Matsubayashi H; Izumi S; Mikami M
Thromb Haemost; 2008 Feb; 99(2):316-23. PubMed ID: 18278180
[TBL] [Abstract][Full Text] [Related]
9. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants.
Arvieux J; Darnige L; Caron C; Reber G; Bensa JC; Colomb MG
Thromb Haemost; 1995 Oct; 74(4):1120-5. PubMed ID: 8560423
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.
Jone DW; Nicholls PJ; Donohoe S; Gallimore MJ; Winter M
Thromb Haemost; 2002 Mar; 87(3):426-30. PubMed ID: 11916074
[TBL] [Abstract][Full Text] [Related]
12. The correlation between lupus anticoagulant and autoantibodies.
Gleicher N; Harlow L; el-Roeiy A
Mt Sinai J Med; 1992 Jan; 59(1):32-7. PubMed ID: 1734235
[TBL] [Abstract][Full Text] [Related]
13. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin.
Bevers EM; Galli M; Barbui T; Comfurius P; Zwaal RF
Thromb Haemost; 1991 Dec; 66(6):629-32. PubMed ID: 1796407
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.
Halbmayer WM; Haushofer A; Schön R; Mannhalter C; Strohmer E; Baumgarten K; Fischer M
Thromb Haemost; 1994 Jan; 71(1):68-72. PubMed ID: 8165648
[TBL] [Abstract][Full Text] [Related]
17. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII.
Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M
Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
Rauch J; Tannenbaum M; Janoff AS
Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
[TBL] [Abstract][Full Text] [Related]
19. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
